EDRN Breast and Ovary Cancer CVC, Study 1: Preliminary validation of breast cancer early detection biomarker candidates from our WHI discovery project

CVC Study 1
No design specified.
Breast and Gynecologic Cancers Research Group

To identify promising candidate plasma early detection biomarkers specific to different molecular subtypes of breast cancer using preclinical specimens from the Women’s Health Initiative.

1.   Conduct a second screen of the most promising breast cancer early detection biomarkers to identify the candidates most suitable for validation. 2.   Validate the top 50 novel early detection biomarkers in an independent sample for breast cancer overall and for several breast cancer subtypes.
Antibody array

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.

Version 5.1.0